ExCEEd Orphan Announces Extension of an Exclusive Distribution Agreement with Mirum Pharmaceuticals for Marketing and Distribution of LIVMARLI™ (maralixibat) to Additional CEE Countries
ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o.,
ExCEEd Orphan announces extension of an exclusive Distribution Agreement with Advicenne for marketing and distribution of Sibnayal® in Estonia, Latvia and Lithuania
ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o.,
ExCEEd Orphan announces opening of its affiliate in Poland
ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in
ExCEEd Orphan announces extension of partnership with Amryt to exclusively distribute Lojuxta® in 17 countries of Central and Eastern Europe (CEE)
ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o.,
Neobiomics AB and ExCEEd Orphan s.r.o. announce an extended partnership for ProPrems® in Estonia, Latvia and Lithuania
Stockholm, Sweden, 17 Nov 2022 – Neobiomics AB and ExCEEd Orphan s.r.o. have
ExCEEd Orphan announces new members of the team in several countries of the CEE region
ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in
Rafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in medicines addressing rare diseases
Jerusalem, Israel and Prague, Czech Republic, August 1st, 2022. Rafa Laboratories LTD. (“Rafa”)
ExCEEd Orphan announces new member of the EO Management team
ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in
ExCEEd Orphan announces partnership with Amryt to exclusively distribute Filsuvez® in Central and Eastern Europe (CEE)
Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to